Dr. Sarafoglou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2450 Riverside Ave 12th floor
Minneapolis, MN 55454Phone+1 612-365-6777- Is this information wrong?
Education & Training
- NYU Grossman School of MedicineResidency, Pediatrics, 1996 - 1999
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Endocrinology, 1990 - 1994
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Pediatrics, 1987 - 1990
- University of AthensClass of 1984
Certifications & Licensure
- NJ State Medical License 1993 - Present
- MN State Medical License 2005 - 2024
- NY State Medical License 1996 - 2006
- American Board of Pediatrics Pediatric Endocrinology
Clinical Trials
- Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation Start of enrollment: 2015 Feb 01
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Adults With Congenital Adrenal Hyperplasia Start of enrollment: 2018 Apr 10
- Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia Start of enrollment: 2018 Sep 06
- Join now to see all
Publications & Presentations
PubMed
- A complement C4-derived glycopeptide is a biomarker for PMM2-CDG.Kishore Garapati, Rohit Budhraja, Mayank Saraswat, Jinyong Kim, Neha Joshi, Gunveen S Sachdeva, Anu Jain, Anna N Ligezka, Silvia Radenkovic, Madan Gopal Ramarajan, Sav...> ;JCI Insight. 2024 Apr 8
- Practice Variation among Pediatric Endocrinologists in the Dosing of Glucocorticoids in Young Children with Congenital Adrenal Hyperplasia.Simpson, L., Palzer, E., , Al-Rayess, H., Lahoti, A., Thornton, P., Heksch, R., Kamboj, M., Stanley, T., Regelmann, M., Gupta, A., Raman, V., Mehta, S., Geffner, M., S...> ;Children. 2023 Nov 29
- Crinecerfont, a CRF1 Receptor Antagonist, Lowers Adrenal Androgens in Adolescents With Congenital Adrenal Hyperplasia.Ron S Newfield, Kyriakie Sarafoglou, Patricia Y Fechner, Natalie J Nokoff, Richard J Auchus, Maria G Vogiatzi, George S Jeha, Nagdeep Giri, Eiry Roberts, Julia Sturgeo...> ;The Journal of Clinical Endocrinology and Metabolism. 2023 Oct 18
- Join now to see all
Journal Articles
- Adrenoleukodystrophy: Guidance for Adrenal Surveillance in Males Identified by Newborn ScreenTakara L Stanley, Kyriakie Sarafoglou, Rose Marino, Manmohan Kamboj, Bradley S Miller, The Journal of Clinical Endocrinology and Metabolism
Press Mentions
- Glycomine’s Natural History Study Informs Potentially Lifesaving Update to Standard of Care for PMM2-CDG PatientsJune 29th, 2021
- Spruce Biosciences Announces Publication of Phase 2 Results for Tildacerfont in Journal of Clinical Endocrinology and MetabolismJune 21st, 2021
- Neurocrine Biosciences Announces Phase 3 Pediatric Study Results of Crinecerfont in Children and Adolescents for the Treatment of Congenital Adrenal Hyperplasia Met Primary and Key Secondary EndpointsOctober 6th, 2023
Grant Support
- Partial Growth Hormone Insensitivity In Idiopathic Short Stature/Small-For-GestaNational Center For Research Resources2006–2009
- Comparison 17-Ohp Measured By Tandem Mass Spectroscopy VS Blood Serum In CAH PANational Center For Research Resources2008
- Aromatase Inhibitor In Males With Adrenal HyperplasiaEunice Kennedy Shriver National Institute Of Child Health &Human Development2004–2006
Professional Memberships
- Member
Hospital Affiliations
- M Health Fairview University of Minnesota Medical CenterMinneapolis, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: